"Northwestern Medicine is proud to have five hospitals ranked among “America’s Best” by U.S. News & World Report, 2021-22. Anchored by Northwestern Memorial Hospital, the #1 hospital in Illinois and a top 10 hospital in the nation, we’re leading the quest for better care and better treatments in the Chicagoland area. With more than 200 locations across Chicagoland, better care and better treatments are never far from home. To learn more, visit our website."

During the past decade, Northwestern University, Bluhm Cardiovascular Institute conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northwestern University, Bluhm Cardiovascular Institute" #1 sponsor was "AtriCure, Inc." with 2 trials, followed by "Abbott Medical Devices" with 1 trials sponsored, "Boston Biomedical Associates" with 1 trials sponsored, "Coram Clinical Trials" with 1 trials sponsored and "Mitralign, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northwestern University, Bluhm Cardiovascular Institute" #1 collaborator was "Cardiovalve Ltd." with 1 trials as a collaborator, "Cardiovascular Research Foundation, New York" with 1 trials as a collaborator, "Columbia University" with 1 trials as a collaborator, "Icahn School of Medicine at Mount Sinai" with 1 trials as a collaborator and "Northwestern University" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Northwestern University, Bluhm Cardiovascular Institute" are "Atrial Fibrillation" (2 trials), "Chronic Symptomatic Functional Tricuspid Regurgitation" (1 trials), "Heart Failure" (1 trials), "Heart Valve Disease" (1 trials) and "Paroxysmal Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Northwestern University, Bluhm Cardiovascular Institute" in a lesser frequency.

Most popular intervention types in "Northwestern University, Bluhm Cardiovascular Institute" are "Device" (4 trials), "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "LARIAT + PVI" (2 trials), "Cardiovalve Transfemoral Tricuspid Valve" (1 trials), "FIRM-Guided Procedure and PVI" (1 trials), "Inotrope" (1 trials) and "Mitralign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Northwestern University, Bluhm Cardiovascular Institute" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Northwestern University, Bluhm Cardiovascular Institute". 1 are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Northwestern University, Bluhm Cardiovascular Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Northwestern University, Bluhm Cardiovascular Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".